- Home
- ZURA vs KOP Comparison
ZURA vs KOP Comparison
Compare ZURA & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- KOP
- Stock Information
- Founded
- ZURA 2022
- KOP 1988
- Country
- ZURA United States
- KOP United States
- Employees
- ZURA N/A
- KOP N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- KOP Forest Products
- Sector
- ZURA Health Care
- KOP Basic Materials
- Exchange
- ZURA Nasdaq
- KOP Nasdaq
- Market Cap
- ZURA 76.6M
- KOP N/A
- IPO Year
- ZURA N/A
- KOP 2006
- Fundamental
- Price
- ZURA $1.37
- KOP $25.29
- Analyst Decision
- ZURA Buy
- KOP Buy
- Analyst Count
- ZURA 7
- KOP 1
- Target Price
- ZURA $14.67
- KOP $64.00
- AVG Volume (30 Days)
- ZURA 406.5K
- KOP 172.1K
- Earning Date
- ZURA 05-08-2025
- KOP 05-09-2025
- Dividend Yield
- ZURA N/A
- KOP 1.27%
- EPS Growth
- ZURA N/A
- KOP N/A
- EPS
- ZURA N/A
- KOP 2.46
- Revenue
- ZURA N/A
- KOP $2,092,100,000.00
- Revenue This Year
- ZURA N/A
- KOP $4.44
- Revenue Next Year
- ZURA N/A
- KOP $2.29
- P/E Ratio
- ZURA N/A
- KOP $10.28
- Revenue Growth
- ZURA N/A
- KOP N/A
- 52 Week Low
- ZURA $0.97
- KOP $22.99
- 52 Week High
- ZURA $6.35
- KOP $54.07
- Technical
- Relative Strength Index (RSI)
- ZURA 54.25
- KOP 44.80
- Support Level
- ZURA $1.06
- KOP $24.43
- Resistance Level
- ZURA $1.59
- KOP $25.75
- Average True Range (ATR)
- ZURA 0.15
- KOP 1.34
- MACD
- ZURA 0.04
- KOP 0.19
- Stochastic Oscillator
- ZURA 63.33
- KOP 69.70
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.